Skip to main content
Premium Trial:

Request an Annual Quote

NanoString Technologies, Rules Based Medicine

Premium
NanoString Technologies has hired Lianne McLean as vice president of marketing in preparation for the commercial launch of the nCounter Analysis System.
 
McLean joined NanoString from Applied Biosystems where she served as director of global strategic marketing in the molecular cell biology division.
 
Prior to Applied Biosystems, McLean spent six years at Affymetrix where she played a role in bringing whole genome expression arrays to market, building a supporting reagents business, and developing the custom and model organism array program. McLean also spent five years at Roche Molecular Diagnostics and Chiron Diagnostics marketing in vitro diagnostics tests for infectious diseases.
 

 
Rules Based Medicine this week said that Matt Zell, managing director of Equity Group Investments, has joined its board of directors in conjunction with a $25 million financing round (see related story, this issue).

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.